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Abstract
Background: To understand the genetics of schizophrenia, a hunt for so-called intermediate phenotypes or
endophenotypes is ongoing. Visual masking has been proposed to be such an endophenotype. However, no systematic
study has been conducted yet to prove this claim. Here, we present the first study showing that masking meets the most
important criteria for an endophenotype.
Methodology/Principal Findings: We tested 62 schizophrenic patients, 39 non-affected first-degree relatives, and 38
healthy controls in the shine-through masking paradigm and, in addition, in the Continuous Performance Test (CPT) and the
Wisconsin Card Sorting Test (WCST). Most importantly, masking performance of relatives was significantly in between the
one of patients and controls in the shine-through paradigm. Moreover, deficits were stable throughout one year. Using
receiver operating characteristics (ROC) methods, we show that the shine-through paradigm distinguishes with high
sensitivity and specificity between schizophrenic patients, first-order relatives and healthy controls.
Conclusions/Significance: The shine-through paradigm is a potential endophenotype.
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Introduction
Schizophrenia is a heterogeneous disease strongly influenced by
genetic disposition. A large variety of candidate genes has been
identified of which each gene, however, explains only a small
proportion of the genetic risk [1]. For this reason, stable markers,
so called endophenotypes, are of primary interest. From the
original five requirements for an endophenotype [2], one is related
to its sensitivity, i.e., an endophenotype should show performance
differences between patients and controls and patients with other
diseases. Three requirements relate to the genetic underpinnings
of the disease of which the most important criterion states that
unaffected relatives must show deteriorated performance com-
pared to controls. The fifth criterion requires state independency
of the test: performance must not vary across time. Further criteria
are practicability and neural explicability [3].
Apart from structural and functional brain measures, several
cognitive candidates have been proposed to be endophenotypes
for schizophrenia. Other promising candidates rely on visual
backward masking where a target is followed by an inter-stimulus
interval (ISI) and a mask. The mask impairs performance on the
target in both schizophrenic patients and healthy controls.
However, masking deficits of patients are much stronger than
those of controls. Masking deficits are of particular interest because
cognitive deficits may be caused by deficient sensory processing
[4]. For decades, masking has been proposed to be a vulnerability
marker, supported by longitudinal studies [5,6], studies with
siblings [7–10], adolescents [11–15], and patients within the
schizophrenia spectrum [14,16].
Whereas there are several masking studies testing certain
requirements an endophenotype has to meet, none of them is
systematic. Many studies compared backward masking perfor-
mance of patients and controls, very few compared relatives and
controls, and none determined masking performance of patients,
relatives and healthy controls altogether. One reason might be that
most masking techniques determine a wide range of ISIs with only
a few trials per ISI which, because of floor and ceiling effects, may
not suffice to reliably determine performance differences of three
populations.
We have introduced a very sensitive backward masking
technique, shine-through, which overcomes floor and ceiling
effects by determining the ISI with an adaptive method [17]. In
the shine-through effect, a vernier stimulus, i.e. two vertical bars
that are slightly offset in the horizontal direction, is presented
(figure 1). The task of the observers is to indicate the offset
direction of the lower bar compared to the upper bar. After the
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vernier, a masking grating follows after a variable ISI. With an
adaptive method, a critical ISI is determined. This technique
yields a very good signal to noise ratio. For example, patients show
almost ten times longer ISIs compared to healthy controls [17].
For an endophenotype, it is important that unaffected relatives
of patients show performance deficits compared to controls. Hence
in the shine-through paradigm, ISIs of relatives should be shorter
than ISIs of patients but longer than the ISIs of controls. In
addition, performance of an endophenotype should be unaffected
by the state of the disease. Hence, masking performance of
patients should be constant when tested on different occasions.
These predictions were tested here.
We also tested performance in the Continuous Performance
Test (CPT) and the Wisconsin Card Sorting Test (WCST) which
are frequently used paradigms. Both tests are often proposed to be
endophenotypes of schizophrenia [18,19]. The CPT is sensitive to
attention deficits and the WCST is sensitive to deficits of executive
functions. We included these tests to compare their power with the
power of the shine-through paradigm.
Methods
Participants
One hundred schizophrenic patients, 40 first-order relatives and
38 healthy controls joined the study. We excluded 38 patients and
1 relative because vernier durations were too long (see below).
Thus, 62 schizophrenic patients, 39 first-order relatives, and 38
healthy controls participated in the main study. Group character-
istics are depicted in table 1. All observers had normal or corrected
to normal visual acuity as determined with the Freiburg visual
acuity test observers had to reach a value of $0.8 for at least one
eye).
Schizophrenic patients were recruited from the Asatiani
psychiatric hospital, the Gotsiridze psycho-neurological dispensa-
ry, and the rehabilitation centre. First-order relatives were asked to
participate after the patients consented. Healthy controls were
recruited from the general population. General exclusion criteria
were drug or alcohol abuse, neurological or other somatic mind-
altering illnesses. All relatives and controls were free from
psychiatric axis I disorders. We did not test for axis II or
schizotypic features. To participate, patients and controls had to
be older than 18 years and younger than 56 years, relatives 14 to
70 years (to include offspring and parents). The age of the patients
ranged from 21 to 52 years, the relatives were between 14 and 66
years old and the controls between 22 and 55 years old (shine-
through performance is roughly constant between 15 and 55 years
of age [20]). The relatives were 20 siblings, 10 parents, and 9
children (four families contributed with 2 relatives, all other
families 1 relative). 37 patients out of 62 did not have any
participating relatives. The peer patients of nine of the relatives
were excluded because of low visual acuity, long VD, or because
they terminated the experiments prematurely.
Ethics approval was obtained from the Georgian National
Council on Bioethics. Observers signed informed consent and
were informed that they could quit the experiments at any time.
Diagnosis and psychopathology
The patients were diagnosed using the DSM-IV by means of an
interview based on the SCID, information from the staff and the
patient records. Psychopathology was assessed by the Scale for the
Assessment of Negative (SANS) and positive (SAPS) Symptoms
[21,22] carried out by an experienced senior psychiatrist (EC).
All patients were receiving neuroleptic medication: 41 took
biperiden, 8 an additional antidepressant, 7 carbamazepine, and 7
received diazepam. Chlorpromazine equivalents are indicated in
table 1.
Shine-through backward masking test paradigm
The shine-through paradigm is described in detail in [17].
Subjects observed the stimuli from a distance of 3.5 m in a dimly
illuminated room. A pixel of the screen comprised about 18’’
(arcsec) at this distance. The stimuli were white (100 cd/m2) on a
black background.
The verniers consisted of two vertical bars of 109 (arc min)
length. The lower bar was slightly offset either to the left or right
with respect to the upper bar. In each trial, the vernier offset
direction was chosen randomly. In a binary task, observers were
asked to indicate this offset direction. Errors were indicated by an
auditory signal. In the masking condition, a grating followed the
vernier. The grating comprised 25 verniers without offset of the
same length as the target vernier. The horizontal distance between
grating elements was about 3.339. The vernier and the central
element of the grating always appeared in the middle of the screen.
Conditions were presented in blocks of 80 trials.
First, we tested unmasked verniers in order to determine the
individual vernier duration using a staircase procedure (figure 1;
[17]). Observers with vernier durations longer than 100 ms were
excluded at this stage to ensure that all observers were rather
‘‘good’’ performers (sensitivity should not be boosted by ‘‘bad’’
performers). 38 out of 100 patients and one relative out of 40 were
excluded because of too long vernier durations (VD).
In the masking experiment, we presented the vernier with the
individual duration of each observer as determined in the previous
step (20 ms was the minimal duration). The vernier offset size was
set to 1.159 for all observers. After the vernier, an ISI followed, i.e.
a blank screen, and then the grating for 300 ms (figure 1B). We
adaptively assessed the target-mask stimulus-onset-asynchrony
(SOA=VD + ISI) which yields a performance level of 75%
correct responses. The starting value of the SOA was 200 ms
which was either decreased or increased to find the individual
threshold. A value of 450 ms was recorded, if observers were
unable to reach 75% correct responses for an SOA of 400 ms [23].
This applied to only 2 patients.
Neuropsychological tests
We administered a computerized version of the Nelson Test
[24], a modified WCST with 48 cards, and the degraded
Figure 1. Procedure. (A) For each observer, we determined the
individual vernier duration (VD) for which 75% correct responses were
reached. (B) In the next step, the vernier was presented with the
individual VD of each observer. The vernier offset was fixed at 1.159. This
vernier was followed by a blank screen (ISI) and a grating comprised of
25 aligned verniers, (SOA=VD + ISI).
doi:10.1371/journal.pone.0014268.g001
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Continuous Performance Test CPT-DS [25] with 3 blocks (720
digits, 10% targets, degradation 40%) and a total duration of 12
minutes. Observers had to detect the pair ‘‘1-9’’. The digits were
presented randomly with a rate of one per second with a
presentation time of 50 ms. In order to assess general cognitive
ability, we administered the LPS3 (Leistungspruefsystem). The
LPS3 tests non-verbal cognitive capabilities using abstract shapes
[26]. The tests were administered in the following order: shine-
through paradigm, WCST, CPT-DS, and LPS3.
Stability of performance on the shine-through paradigm
To test stability of performance in the shine-through paradigm,
we asked patients and controls to participate in a second and a
third session about six and twelve months after the first session,
respectively (relatives were not tested). We tested only 23 of the
patients who participated in the first session (for each participant,
we used the same individual VD for the three tests as determined
in the first testing). For the third session, 5 patients dropped out
because of various reasons (no address, problems of transportation
from rural regions).
Data Analysis
For statistical analysis, we selected one particular meaningful
variable for each test. For the shine-through paradigm, we chose
the SOA, d’ for the CPT-DS [27], and the total number of errors
(WCST-Err) for the WCST [28,29].
To account for possible correlations of SOA, CPT-DS, WCST-
Err, and LPS3 between members of a family, the data were
subjected to General Estimating Equations (GEE), procedure
genmode SAS 9.1. In order to adjust for education, gender and
age these variables were included in the model as covariates. The
shine-through data (SOA) were log-transformed to obtain
normally distributed data (figures and tables were not log-
transformed). All other variables were normally distributed.To
investigate the diagnostic power of the tests, we computed
Receiver Operating Characteristics (ROC) curves and determined
the area under the curves (AUC). Differences between the AUCs
were tested by non-parametric tests [30]. Sensitivity and specificity
were calculated to maximize their sum (sensitivity and specificity
relate to comparisons between schizophrenic patients and
relatives/controls but not to comparisons with other (psychiatric)
diseases). Stability of shine-through performance was analysed by a
repeated measures analysis with 3 intra-individual (time points)
and one between group factor (patients vs. controls). Additionally,
we described the stability by intraclass correlation coefficients in a
mixed two-way effects model. The influence of the psychopath-
ological variables (SANS and SAPS) on the SOA was examined by
a general linear model.
Results
Group characteristics are shown in table 1. Controls had higher
education levels than relatives (p = 0.006) and patients (p,0.0001).
The patient group had a higher proportion of males (41 vs. 21)
than the relative group (13 vs. 26) and the control group (17 vs.
21). VDs were almost identical for controls and relatives but higher
for the patients (table 1).
The GEE showed that the group factor was significant in all
three tests (p,0.0001; figure 2). Schizophrenic patients performed
worse than healthy controls (p,0.0001, in each test) and relatives
(shine-through p,0.0001, CPT-DS p=0.0002, WCST errors
p=0.009). Relatives performed significantly worse than controls in
the shine-through test (p=0.0001) but not in the CPT-DS nor in
the WCST (CPT-DS: p=0.55, WCST-Err: 0.16; see figure 2)).
Performance in the LPS3 was significantly impaired for patients
compared to relatives and controls. There was no significant
difference between relatives and controls.
Power of discrimination
Schizophrenic patients vs. healthy controls. ROC
analysis showed that the shine-through paradigm differentiates
better than the other tests between patients and controls (figure 3).
The AUC for the shine-through paradigm, the CPT-DS, and the
WCST were: 0.916, 0.779, and 0.791, respectively. An AUC of
0.5 indicates the test has no discriminative power. Comparisons of
the AUCs by the DeLong test revealed that the shine-through
paradigm differentiates significantly better between both groups
than the other tests (shine-through vs. CPT-DS: p=0.005; shine-
through vs. WCST: p=0.02).
We found a sensitivity of 87% (p,0.0005) and a specificity of
89% (p,0.0005) for the shine-through paradigm. Sensitivity was
59% for the CPT-DS (p=0.12) and 73% for the WCST (p,0.08),
Table 1. Demographic data.
Schizophrenic patients (N=62) Non-affected first-order relatives (N=39)Healthy controls (N=38)
Mean SD Mean SD Mean SD
Female 21/62 26/39 21/38
Age 35.23 8.05 35.03 15.87 35.39 10.22
Age range 21–52 14–66 20–55
Education 12.81 2.42 13.15 3.47 15.24 3.03
Illness duration 11.54 8.34
SANS 10.60 5.56
SAPS 10.42 3.11
CPZ 511.3 469.4
LPS3 17.52 6.09 22.74 5.66 23 6.7
VD 43.2 27.8 27.7 18.98 27.4 16.22
Gender, age (ys), education (ys), duration of illness (ys), SANS (Scale for the Assessment of Negative Symptoms), SAPS (Scale for the Assessment of Positive Symptoms),
and vernier duration (VD). There are more males in the schizophrenia group. Controls are better educated than patients and relatives. The VD of schizophrenic patients
is nearly twice that of relatives and controls. Indicated are means and standard deviations.
doi:10.1371/journal.pone.0014268.t001
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Figure 2. GEE results of shine-through, CPT-DS, and WCST. Dependent variables were SOA (stimulus onset asynchrony), d’, and total number
of errors, respectively. Bars indicate performance of schizophrenic patients (schiz), non-affected first-order relatives (rel), and healthy controls (con).
Error bars indicate standard errors. Schizophrenic patients perform worse than controls in all tests. The difference between relatives and healthy
controls is only significant in the shine-through paradigm; * p,0.01, ** p,0.001, *** p,0.0001.
doi:10.1371/journal.pone.0014268.g002
Figure 3. ROC (receiver operating characteristics) curves for the shine-through paradigm, the CPT-DS, and WCST. (A) ROC curves for
schizophrenic patients and healthy controls. The x-axis indicates the error of the second kind (100%-specificity). The y-axis indicates sensitivity. The
area under the curve (AUC) shows the discriminative power between the two groups. The diagonal from (0,0) to (100,100) with AUC=0.5 indicates a
total lack of discriminative power. AUC values are given in the text. All tests discriminate well between schizophrenic patients and healthy controls
with the shine-through paradigm showing the significantly best discrimination. (B) ROC curves for non-affected first-order relatives of schizophrenic
patients and healthy controls. All ROC curves are more attenuated than the ones comparing patients and controls (figure 3 A). Again, the shine-
through paradigm yields the highest discriminative power.
doi:10.1371/journal.pone.0014268.g003
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specificity 86% for the CPT-DS (p,0.002) and 90% for the
WCST (p,0.0005).
Relatives vs. healthy controls. The AUCs show that the
shine-through paradigm discriminates well between relatives and
controls (0.743). The AUCs related to the other tests were
substantially lower (CPT-DS: 0.548; WCST: 0.660). The power of
discrimination of the shine-through paradigm was significantly
higher than the power of the CPT-DS (p=0.009). There was no
significant difference of power between shine-through and the
WCST (p=0.35).
For the shine-through test, sensitivity and specificity were 67%
(p=0.03) and 82% (p,0.0005), respectively. The sensitivity was
39% for the CPT-DS and 46% for the WCST. Specificity was
75% for the CPT-DS (p=0.002) and 82% for the WCST
(p,0.0005).
Stability of shine-through. 18 schizophrenic patients and
20 controls participated in all three sessions (figure 4). A repeated
measures analysis showed a decrease of the SOA across time with
only a tendency to significance in both groups (F[1,71] = 2.97;
p=0.06; partial eta-square = 0.08). Patients performed
dramatically worse on all three occasions (F[1,36] = 34.2;
p,0.0001; partial eta-square = 0.49). There was no significant
interaction of group and time. Intraclass correlations were 0.67
(patients) and 0.74 (controls) between the first and the third test
session.
Psychopathological measures in the schizophrenic patients
changed moderately between sessions. SAPS decreased from 9.8
to 8.6 whereas SANS increased from 8.4 to 11.3. A mixed linear
model revealed no significant influence of SANS and SAPS on
performance in the shine-through paradigm.
Discussion
For decades, visual masking is suggested to be a vulnerability
marker [4]. Until now, there was no systematic masking study
where the major criteria of an endophenotype within a single
paradigm were tested. Here, we showed the shine-through
paradigm is a potential endophenotype because it meets the
major criteria proposed by Gottesman and Gould [2] and the
practicability and explicability criteria proposed by Turetsky et al.
[3].
The shine-through paradigm and the endophenotype
concept
1. Association with the disease [2]. Our results show that the
shine-through paradigm is associated with schizophrenia revealing
a remarkable sensitivity of 87% and specificity of 89%. Also the
effect size of the shine-through test, as compared between patients
and controls, shows a large value of 1.96 (table 2). Furthermore,
we excluded patients with VDs longer than 100 ms. Hence, our
patients are rather good performers. Including bad performers
might even have increased sensitivity and specificity. Our results
are in good agreement with most masking studies which have
consistently shown that performance of schizophrenic patients is
deteriorated compared to controls. However, we cannot compare
the discriminative power of the shine-through paradigm with that
of other masking paradigms because in these studies sensitivity and
specificity were never computed.
Unmasked VDs were prolonged in the schizophrenic patients
compared to controls. We compensated for this effect by providing
individual VDs in the masking conditions as most studies on
masking do. It has been proposed that vernier acuity itself is an
endophenotype [31,32]. In our study, unmasked vernier durations
were not significantly longer in relatives of patients compared to
controls (however, [31,32] used much longer VDs).
2. Relatives [2]. Non-affected first-order relatives are signifi-
cantly impaired in the shine-through test compared to controls.
Thus, the shine-through test discriminates well between patients
and controls and between relatives and healthy controls. Also the
effect size between relatives and controls was large for the shine-
through test (0.99).
The relatives group had a wider age range and a lower education
level than controls. However, GEE with age and education as
covariates still yielded significant differences between relatives and
controls (figure 2). Moreover, education did not correlate with
shine-through performance; global cognitive ability (LPS3) showed
no significant difference between relatives and controls.
3. Heritability [2]. Our study was not designed to investigate the
heritability of the shine-through test. One recent study of
heritability of backward masking, different from the shine-through
paradigm, has shown moderate familial correlations [33].
4. State independency. Two studies determined stable masking
performance for a period of more than 1.5 years [5,6]. Also in our
study masking performance was roughly stable throughout one
year. Intraclass correlation coefficients show a high stability across
time (however, patients showed only a weak clinical recovery).
5. Practicability [3]. The shine-through paradigm is easily applicable
because it can be applied with two blocks of measurements each
lasting less than 5 min. VD estimation takes another 10–20 min.
6. In addition, the shine-through paradigm offers insights into
the mechanisms of deficient visual information processing of
schizophrenic patients. For example, schizophrenic patients are
not simply slower in processing visual stimuli. It seems that patients
have problems suppressing mask information [34–36]. The shine-
through effect can be understood in terms of low level neural
interactions as shown by computer simulations [37,38].
Methodological considerations
Visual masking in general is a very promising candidate for an
endophenotype as many previous studies have shown. In most of
these studies, a certain number of ISIs are pre-selected and percent
correct or the (bias prone) hit rate is determined per ISI. To keep
the experiment feasible, only a few trials per ISI are presented.
This often yields a weak signal to noise ratio with one of the
populations performing either in the floor or ceiling region.
Therefore, it is unlikely that performance differences of three
Figure 4. Performance in the shine-through paradigm for 18
schizophrenic patients and 20 controls at three occasions.
Session II took place about 6 months after session I and session III about
6 months after session II. Schizophrenic patients show a weak (but
statistically non significant) improvement with time. Error bars show
standard errors.
doi:10.1371/journal.pone.0014268.g004
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populations with very different performance levels can reliably be
determined. However, this is important for an endophenotype and
for genetic analysis. For this reason, we propose that using an
adaptive method without predefined ISIs is a more efficient
strategy because the adaptive method ‘‘chooses’’ the ISIs which
are most informative for each participant individually.
We also tested performance in the CPT and the WCST which
are frequently used tests often proposed to be endophenotypes of
schizophrenia [18,19]. We included these test to compare their
power with the power of the shine-through paradigm. We found
that the shine-through paradigm has a higher sensitivity and
specificity than both the CPT and WCST for both the comparison
between controls and patients and relatives of patients and
controls.
Limitations
First, all patients received medication. However, backward
masking does usually not deteriorate with drug application [39].
Second, controls were better educated than patients and relatives,
the age distribution of the relatives was not well matched with that
of the controls, and the gender distribution varied between the
groups (e.g. the patient group containing more males than the
relatives group). However, GEE analyses with gender, education,
and age as covariates still yielded significant differences between
relatives and controls for the shine-through test. A third limitation
of the study is the rather small sample size of first-order relatives.
Summary
The shine-through paradigm is a potential endophenotype for
schizophrenia having both a high sensitivity and specificity for
detecting performance differences between patients and controls
and between relatives and controls. Future research has to probe
whether masking deficits are associated with genetic variants in the
patients. The genetic variants and related neurophysiological
mechanisms underlying the masking deficits may be different from
those of other endophenotypes, such as the WCST. Thus, different
endophenotypes may lead to the characterization of subgroups of
schizophrenia.
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